Johanna Mercier, Chief Communications and Corporate Affairs Officer at Gilead Sciences ($GILD), sold about $16.3 million in company shares across twenty open market transactions over the past year. Her most recent sale occurred on February 17, 2026. These sales rank her 785th among 11,678 insiders by total value sold, above the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 3000 | $144.23 | 131,779.0000 | 1,256,000,000 | 2.23% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Common Stock | 6617 | $0.00 | 137,995.0000 | 1,256,000,000 | 5.04% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | F | Common Stock | 3216 | $148.56 | 134,779.0000 | 1,256,000,000 | 2.33% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Restricted Stock Unit | 6617 | $0.00 | 21,057.0000 | 1,256,000,000 | 23.91% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Restricted Stock Unit | 9590 | $0.00 | 30,647.0000 | 1,256,000,000 | 45.54% | 0.00% |
| March 10, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Non-qualified Stock Option (Right to Buy) | 35880 | $0.00 | 35,880.0000 | 1,256,000,000 | 9999.99% | 0.00% |
| Feb. 27, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Common Stock | 11090 | $0.00 | 131,378.0000 | 1,256,000,000 | 9.22% | 0.00% |
| Feb. 17, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Common Stock | 25000 | $66.64 | 148,288.0000 | 1,256,000,000 | 20.28% | 0.00% |
| Feb. 17, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 48,110.0000 | 1,256,000,000 | 34.20% | 0.00% |
| Feb. 17, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 18405 | $154.18 | 129,883.0000 | 1,256,000,000 | 12.41% | 0.00% |
| Feb. 17, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 9395 | $154.91 | 120,488.0000 | 1,256,000,000 | 7.23% | 0.00% |
| Feb. 17, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | S | Common Stock | 200 | $155.62 | 120,288.0000 | 1,256,000,000 | 0.17% | 0.00% |
| Feb. 3, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | A | Common Stock | 44867 | $0.00 | 148,088.0000 | 1,256,000,000 | 43.47% | 0.00% |
| Feb. 3, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Comm & Corp Aff Officer | F | Common Stock | 24800 | $143.28 | 123,288.0000 | 1,256,000,000 | 16.75% | 0.00% |
| Jan. 15, 2026 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $124.31 | 103,221.0000 | 1,256,000,000 | 2.82% | 0.00% |
| Dec. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $122.00 | 106,221.0000 | 1,256,000,000 | 2.75% | 0.00% |
| Dec. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3842 | $0.00 | 27,674.0000 | 1,256,000,000 | 12.19% | 0.00% |
| Dec. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3842 | $0.00 | 111,035.0000 | 1,256,000,000 | 3.58% | 0.00% |
| Dec. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1814 | $121.34 | 109,221.0000 | 1,256,000,000 | 1.63% | 0.00% |
| Nov. 17, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 25524 | $125.83 | 109,669.0000 | 1,256,000,000 | 18.88% | 0.00% |
| Nov. 17, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 2476 | $126.26 | 107,193.0000 | 1,256,000,000 | 2.26% | 0.00% |
| Nov. 17, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 25000 | $0.00 | 73,110.0000 | 1,256,000,000 | 25.48% | 0.00% |
| Nov. 17, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 25000 | $66.64 | 135,193.0000 | 1,256,000,000 | 22.69% | 0.00% |
| Oct. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $118.08 | 110,193.0000 | 1,256,000,000 | 2.65% | 0.00% |
| Sept. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $113.57 | 113,193.0000 | 1,255,000,000 | 2.58% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3844 | $0.00 | 118,012.0000 | 1,255,000,000 | 3.37% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3844 | $0.00 | 31,516.0000 | 1,255,000,000 | 10.87% | 0.00% |
| Sept. 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1819 | $115.25 | 116,193.0000 | 1,255,000,000 | 1.54% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 700 | $66.64 | 117,868.0000 | 1,255,000,000 | 0.60% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 11800 | $66.64 | 128,968.0000 | 1,255,000,000 | 10.07% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 11800 | $118.50 | 117,168.0000 | 1,255,000,000 | 9.15% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 700 | $66.64 | 117,868.0000 | 1,255,000,000 | 0.60% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 700 | $118.97 | 117,168.0000 | 1,255,000,000 | 0.59% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 11800 | $66.64 | 128,968.0000 | 1,255,000,000 | 10.07% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 11800 | $118.51 | 117,168.0000 | 1,255,000,000 | 9.15% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 700 | $118.97 | 117,168.0000 | 1,255,000,000 | 0.59% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 2800 | $118.51 | 114,368.0000 | 1,255,000,000 | 2.39% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 200 | $118.97 | 114,168.0000 | 1,255,000,000 | 0.17% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 11800 | $0.00 | 111,310.0000 | 1,255,000,000 | 9.58% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 700 | $0.00 | 110,610.0000 | 1,255,000,000 | 0.63% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 11800 | $0.00 | 98,810.0000 | 1,255,000,000 | 10.67% | 0.00% |
| Aug. 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 700 | $0.00 | 98,110.0000 | 1,255,000,000 | 0.71% | 0.00% |
| July 15, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $111.03 | 117,168.0000 | 1,255,000,000 | 2.50% | 0.00% |
| June 16, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $110.17 | 120,168.0000 | 1,255,000,000 | 2.44% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3843 | $0.00 | 124,995.0000 | 1,255,000,000 | 3.17% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3843 | $0.00 | 35,360.0000 | 1,255,000,000 | 9.80% | 0.00% |
| June 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1827 | $110.09 | 123,168.0000 | 1,255,000,000 | 1.46% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 12500 | $66.64 | 136,652.0000 | 1,255,000,000 | 10.07% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 12500 | $107.52 | 124,152.0000 | 1,255,000,000 | 9.15% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 12500 | $66.64 | 136,652.0000 | 1,255,000,000 | 10.07% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 12500 | $0.00 | 135,610.0000 | 1,255,000,000 | 8.44% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Non-qualified Stock Option (Right to Buy) | 12500 | $0.00 | 123,110.0000 | 1,255,000,000 | 9.22% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 3000 | $107.52 | 121,152.0000 | 1,255,000,000 | 2.42% | 0.00% |
| May 22, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 12500 | $107.52 | 124,152.0000 | 1,255,000,000 | 9.15% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | M | Restricted Stock Unit | 1435 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | M | Common Stock | 1435 | $0.00 | 3,535.0000 | 103,700,000 | 68.33% | 0.00% |
| May 21, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | A | Restricted Stock Unit | 3318 | $0.00 | 3,318.0000 | 103,700,000 | 9999.99% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 3907 | $117.21 | 124,152.0000 | 1,255,000,000 | 3.05% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Restricted Stock Unit | 11090 | $0.00 | 39,203.0000 | 1,255,000,000 | 39.45% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 49020 | $0.00 | 49,020.0000 | 1,255,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 8080 | $0.00 | 28,113.0000 | 1,255,000,000 | 22.32% | 0.00% |
| March 10, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 8080 | $0.00 | 128,059.0000 | 1,255,000,000 | 6.73% | 0.00% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 19793 | $0.00 | 94,933.0000 | 1,255,000,000 | 26.34% | 0.00% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 70712 | $0.00 | 165,645.0000 | 1,255,000,000 | 74.49% | 0.01% |
| Feb. 4, 2025 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 45666 | $97.99 | 119,979.0000 | 1,255,000,000 | 27.57% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3752 | $0.00 | 36,193.0000 | 1,254,000,000 | 9.39% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3752 | $0.00 | 76,879.0000 | 1,254,000,000 | 5.13% | 0.00% |
| Dec. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1739 | $92.34 | 75,140.0000 | 1,254,000,000 | 2.26% | 0.00% |
| Nov. 6, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 5000 | $91.28 | 73,127.0000 | 1,254,000,000 | 6.40% | 0.00% |
| Sept. 12, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 13432 | $83.25 | 78,127.0000 | 1,258,000,000 | 14.67% | 0.00% |
| Sept. 12, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 15925 | $84.23 | 91,559.0000 | 1,258,000,000 | 14.82% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3752 | $0.00 | 39,945.0000 | 1,258,000,000 | 8.59% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1734 | $81.44 | 107,484.0000 | 1,258,000,000 | 1.59% | 0.00% |
| Sept. 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3752 | $0.00 | 109,218.0000 | 1,258,000,000 | 3.56% | 0.00% |
| Aug. 28, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 9513 | $78.03 | 105,466.0000 | 1,258,000,000 | 8.27% | 0.00% |
| Aug. 13, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 5490 | $73.98 | 114,979.0000 | 1,258,000,000 | 4.56% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3751 | $0.00 | 43,697.0000 | 1,258,000,000 | 7.91% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3751 | $0.00 | 122,183.0000 | 1,258,000,000 | 3.17% | 0.00% |
| June 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1714 | $65.25 | 120,469.0000 | 1,258,000,000 | 1.40% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | A | Non-Qualified Stock Option | 2982 | $0.00 | 2,982.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | A | Restricted Stock Unit | 1435 | $0.00 | 1,435.0000 | 101,000,000 | 9999.99% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | M | Restricted Stock Unit | 2100 | $0.00 | 0.0000 | 101,000,000 | 100.00% | 0.00% |
| May 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | M | Common Stock | 2100 | $0.00 | 2,100.0000 | 101,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Restricted Stock Unit | 17305 | $0.00 | 47,448.0000 | 1,258,000,000 | 57.41% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3025 | $0.00 | 116,172.0000 | 1,258,000,000 | 2.67% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 6819 | $0.00 | 122,991.0000 | 1,258,000,000 | 5.87% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 4559 | $75.12 | 118,432.0000 | 1,258,000,000 | 3.71% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 36,962.0000 | 1,258,000,000 | 7.56% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 6819 | $0.00 | 30,143.0000 | 1,258,000,000 | 18.45% | 0.00% |
| March 10, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 87970 | $0.00 | 87,970.0000 | 1,258,000,000 | 9999.99% | 0.01% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 22509 | $78.26 | 113,147.0000 | 1,258,000,000 | 16.59% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 53969 | $0.00 | 135,656.0000 | 1,258,000,000 | 66.07% | 0.00% |
| Jan. 31, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 20086 | $0.00 | 81,687.0000 | 1,258,000,000 | 32.61% | 0.00% |
| Jan. 9, 2024 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | S | Common Stock | 8242 | $85.23 | 82,729.0000 | 1,258,000,000 | 9.06% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 2730 | $0.00 | 92,218.0000 | 1,262,000,000 | 3.05% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1247 | $79.02 | 90,971.0000 | 1,262,000,000 | 1.35% | 0.00% |
| Dec. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 2730 | $0.00 | 39,987.0000 | 1,262,000,000 | 6.39% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1256 | $76.00 | 89,488.0000 | 1,262,000,000 | 1.38% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 2730 | $0.00 | 90,744.0000 | 1,262,000,000 | 3.10% | 0.00% |
| Sept. 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 2730 | $0.00 | 42,717.0000 | 1,262,000,000 | 6.01% | 0.00% |
| July 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 7505 | $0.00 | 51,500.0000 | 1,262,000,000 | 17.06% | 0.00% |
| July 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 3174 | $77.66 | 48,326.0000 | 1,262,000,000 | 6.16% | 0.00% |
| July 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 7505 | $0.00 | 45,447.0000 | 1,262,000,000 | 14.17% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 1272 | $78.12 | 43,995.0000 | 1,262,000,000 | 2.81% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 2730 | $0.00 | 52,952.0000 | 1,262,000,000 | 4.90% | 0.00% |
| June 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 2730 | $0.00 | 45,267.0000 | 1,262,000,000 | 6.42% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | A | Restricted Stock Unit | 2100 | $0.00 | 2,100.0000 | 98,900,000 | 9999.99% | 0.00% |
| May 17, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Mercier Johanna | Director | A | Non-Qualified Stock Option | 4290 | $0.00 | 4,290.0000 | 98,900,000 | 9999.99% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 3025 | $0.00 | 47,283.0000 | 1,262,000,000 | 6.01% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 5116 | $79.50 | 82,225.0000 | 1,262,000,000 | 5.86% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 7951 | $0.00 | 87,341.0000 | 1,262,000,000 | 10.02% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Common Stock | 3025 | $0.00 | 79,390.0000 | 1,262,000,000 | 3.96% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | M | Restricted Stock Unit | 7951 | $0.00 | 39,332.0000 | 1,262,000,000 | 16.82% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Restricted Stock Unit | 16350 | $0.00 | 55,682.0000 | 1,262,000,000 | 41.57% | 0.00% |
| March 10, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 74565 | $0.00 | 74,565.0000 | 1,262,000,000 | 9999.99% | 0.01% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 29124 | $0.00 | 53,420.0000 | 1,262,000,000 | 119.87% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | A | Common Stock | 38270 | $0.00 | 91,690.0000 | 1,262,000,000 | 71.64% | 0.00% |
| Jan. 24, 2023 | GILEAD SCIENCES, INC. | $GILD | Mercier Johanna | Chief Commercial Officer | F | Common Stock | 15325 | $84.02 | 76,365.0000 | 1,262,000,000 | 16.71% | 0.00% |